Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region
Thermo Fisher Scientific's phase-appropriate service provides access to full cGMP quality plasmid material regardless of clinical phase of development, with the option to add enhanced traceability and/or customized documentation as needed. This unique approach allows for flexibility in defining a solution that works for your organization from both a cost and quality perspective.